Pregabalin Extended-Release Tablets

Label at a glance#

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 70771-1739-3

Pregabalin extended-release tablets, 82.5 mg

Rx only

30 tablets

NDC 70771-1740-3

Pregabalin extended-release tablets, 165 mg

Rx only

30 tablets

NDC 70771-1741-3

Pregabalin extended-release tablets, 330 mg

Rx only

30 tablets

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

• Pregabalin
• HYPROMELLOSE 2208 (15000 MPA.S)
• CELLULOSE, MICROCRYSTALLINE
• HYDROXYPROPYL CELLULOSE (90000 WAMW)
• CROSPOVIDONE (120 .MU.M)
• POLYETHYLENE GLYCOL 2000000
• POLYETHYLENE GLYCOL 7000000
• MAGNESIUM STEARATE
• HYPROMELLOSE 2910 (6 MPA.S)
• TITANIUM DIOXIDE
• POLYETHYLENE GLYCOL 8000
• FERRIC OXIDE YELLOW
• FERRIC OXIDE RED
• FD&C RED NO. 40
• D&C YELLOW NO. 10
• ALUMINUM OXIDE

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 38 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.